Citation

Duval F, Mokrani MC, Monreal J, Weiss T, Fattah S, Hamel B, Macher JP. Dialogues Clin. Neurosci. 2002; 4(4): e417.

Copyright

(Copyright © 2002, Les Laboratoires Servier)

DOI

10.31887/DCNS.2002.4.4/fduval

PMID

22033833

PMCID

PMC3181696

Abstract

Disturbances in the serotonin (5-hydroxytryptamine, 5-HT) system constitute the neurobiological abnormality most consistently associated with suicide. This abnormality could be a marker of vulnerability predisposing individuals to auto-aggressive and impulsive behavior. However, other abnormalities, such as hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis, have also been described in suicide victims. While inhibitory effects of adrenocorticosteroids on 5-HT(1A) receptor function have been shown in animals, HPA axis hyperactivity does not seem to be responsible for the reduced 5-HT activity found in depressed patients with a history of suicidal behavior. On the other hand, hypothalamic-pituitarythyroid (HPT) axis dysfunction, frequently observed in depression, may represent a compensatory response to reduced central 5-HT neurotransmission. Moreover, in depressed patients with a history of suicidal behavior, the absence of a functional link between HPT and dopamine activity at the hypothalamic level may be implicated in the pathophysiology of suicidal behavior. Future research is needed to determine why compensatory mechanisms are not efficient in patients with suicidal behavior.

Language: en

Keywords

suicide; depression; serotonin; dopamine; dexamethasone suppression test; d-fenfluramine test; thyrotropin-reieasing hormone test